mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.05 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.05 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.06 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.06 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.07 |